Counterpoint: should epidermal growth factor receptor mutations be routinely tested for in patients with lung cancer? No

Chest. 2013 Mar;143(3):600-602. doi: 10.1378/chest.12-2548.
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / genetics
  • DNA Mutational Analysis
  • Diagnostic Tests, Routine
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics*
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors

Substances

  • Protein Kinase Inhibitors
  • Protein-Tyrosine Kinases